Weighted Average Number of Shares Outstanding, Basic of Edgewise Therapeutics, Inc. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2020 to Q3 2025.
  • Edgewise Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 105M shares, a 12.5% increase year-over-year.
  • Edgewise Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 92.4M shares, a 45% increase from 2023.
  • Edgewise Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 63.7M shares, a 18.9% increase from 2022.
  • Edgewise Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 53.6M shares, a 42.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Edgewise Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 105M +11.7M +12.5% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 105M +11.4M +12.2% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 95.1M +7.56M +8.64% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 92.4M +28.7M +45% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 93.8M +30.4M +47.8% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 93.5M +30.1M +47.5% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 87.6M +24.3M +38.4% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 63.7M +10.1M +18.9% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 63.5M +11.6M +22.4% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 63.4M +13.8M +27.7% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 63.3M +13.7M +27.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 53.6M +16.1M +42.8% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024
Q3 2022 51.8M +2.58M +5.24% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 49.6M +364K +0.74% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 49.5M +48M +3076% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 37.5M 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 49.3M 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 49.3M 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 1.56M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022

Edgewise Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 92.4M +28.7M +45% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 63.7M +10.1M +18.9% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 53.6M +16.1M +42.8% 01 Jan 2022 31 Dec 2022 10-K 22 Feb 2024
2021 37.5M +36.8M +4978% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 739K 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.